Medicaid Prescription Drug Policies and Medication Access and Continuity: Findings From Ten States
Medicaid Prescription Drug Policies and Medication Access and Continuity: Findings From Ten States
复制标题
DOI：
10.1176/appi.ps.60.5.601
复制
发表时间：
2009-05-01
影响因子：
3.8
通讯作者：
Regier, Darrel A.
中科院分区：
文献类型：
--
作者：
West, Joyce C.;Wilk, Joshua E.;Regier, Darrel A.
目的：本研究的目的是比较10个州医疗补助计划中精神病患者的用药途径问题，评估与用药途径问题相关的不良事件，并确定处方药利用管理是否与途径问题和不良事件相关。方法：随机抽取美国医学协会主档案中的精神科医生(N=4,866)。62%的人做出了回应；32%的人治疗了Medicaid患者，并被随机分配了一个开始日期和时间来报告两名Medicaid患者(N=1,625名患者)。结果：在过去的一年中，48.3%+/-2.0%的患者报告了药物获取问题，最低和最高比率的州之间的绝对差异为37.6%(P
Objectives: The aims of this study were to compare medication access problems among psychiatric patients in ten state Medicaid programs, assess adverse events associated with medication access problems, and determine whether prescription drug utilization management is associated with access problems and adverse events. Methods: Psychiatrists from the American Medical Association's Masterfile were randomly selected (N=4,866). Sixty-two percent responded; 32% treated Medicaid patients and were randomly assigned a start day and time to report on two Medicaid patients (N=1,625 patients). Results: A medication access problem in the past year was reported for a mean +/- SE of 48.3%+/- 2.0% of the patients, with a 37.6% absolute difference between states with the lowest and highest rates (p